133 related articles for article (PubMed ID: 2241106)
1. Factors in prostate cancer metastasis.
Geldof AA; Rao BR
Anticancer Res; 1990; 10(5A):1303-6. PubMed ID: 2241106
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin treatment increases metastasis of prostate tumor (R3327-MatLyLu).
Geldof AA; Rao BR
Anticancer Res; 1988; 8(6):1335-9. PubMed ID: 3218966
[TBL] [Abstract][Full Text] [Related]
3. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
4. Radionuclide therapy for prostate cancer lumbar metastasis prolongs symptom-free survival in a rat model.
Geldof AA; van den Tillaar PL; Newling DW; Teule GJ
Urology; 1997 May; 49(5):795-801. PubMed ID: 9145995
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
Chang CJ; Ghosh PK; Hu YF; Brueggemeier RW; Lin YC
Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076
[TBL] [Abstract][Full Text] [Related]
6. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ
Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342
[TBL] [Abstract][Full Text] [Related]
7. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
Zeng Y; Opeskin K; Goad J; Williams ED
Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
[TBL] [Abstract][Full Text] [Related]
8. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
9. Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo.
Achbarou A; Kaiser S; Tremblay G; Ste-Marie LG; Brodt P; Goltzman D; Rabbani SA
Cancer Res; 1994 May; 54(9):2372-7. PubMed ID: 8162583
[TBL] [Abstract][Full Text] [Related]
10. Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer.
Shukeir N; Arakelian A; Kadhim S; Garde S; Rabbani SA
Cancer Res; 2003 May; 63(9):2072-8. PubMed ID: 12727822
[TBL] [Abstract][Full Text] [Related]
11. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells.
Li L; Yang G; Ebara S; Satoh T; Nasu Y; Timme TL; Ren C; Wang J; Tahir SA; Thompson TC
Cancer Res; 2001 Jun; 61(11):4386-92. PubMed ID: 11389065
[TBL] [Abstract][Full Text] [Related]
12. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
[TBL] [Abstract][Full Text] [Related]
13. Metastasis-enhancing effect of heparin and its relationship to a lipoprotein factor.
Chan SY; Pollard M
J Natl Cancer Inst; 1980 May; 64(5):1121-5. PubMed ID: 6929014
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
[TBL] [Abstract][Full Text] [Related]
15. Metastasis of prostate tumor cells to bronchus associated lymphoid tissue.
Geldof AA; Rao BR
In Vivo; 1989; 3(2):87-91. PubMed ID: 2485140
[TBL] [Abstract][Full Text] [Related]
16. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
17. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice.
Sato N; Gleave ME; Bruchovsky N; Rennie PS; Beraldi E; Sullivan LD
Cancer Res; 1997 Apr; 57(8):1584-9. PubMed ID: 9108464
[TBL] [Abstract][Full Text] [Related]
18. The metastatic spread of kidney and prostate cancers in man.
Viadana E; Bross ID; Pickren JW
Neoplasma; 1976; 23(3):323-32. PubMed ID: 958534
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
[TBL] [Abstract][Full Text] [Related]
20. Influence of high-intensity focused ultrasound on the development of metastases.
Oosterhof GO; Cornel EB; Smits GA; Debruyne FM; Schalken JA
Eur Urol; 1997; 32(1):91-5. PubMed ID: 9266238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
